INO 5042

Drug Profile

INO 5042

Latest Information Update: 28 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Innothera
  • Class Cardiotonics; Small molecules; Vascular disorder therapies
  • Mechanism of Action Dinoprostone receptor antagonists; Prostaglandin synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Venous insufficiency

Most Recent Events

  • 05 Mar 1999 Two preclinical studies have been added to the Vascular Disorders pharmacodynamics section ,
  • 03 Jun 1998 New profile
  • 03 Jun 1998 Phase-I clinical trials for Venous insufficiency in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top